| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Total Income - EUR | 0 | 0 | 56 | 0 | 0 | 0 | - | - | - | - |
| Total Expenses - EUR | 12.489 | 17.769 | 9.434 | 13.731 | 0 | 0 | - | - | - | - |
| Gross Profit/Loss - EUR | -12.489 | -17.769 | -9.377 | -13.731 | 0 | 0 | - | - | - | - |
| Net Profit/Loss - EUR | -12.489 | -17.769 | -9.377 | -13.731 | 0 | 0 | - | - | - | - |
| Employees | 1 | 1 | 1 | 1 | 0 | 0 | - | - | - | - |
Check the financial reports for the company - Odelga Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 43 | 42 | 42 | 41 | 40 | 39 | - | - | - | - |
| Current Assets | 5.167 | 5.424 | 2.953 | 2.746 | 2.693 | 2.642 | - | - | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Receivables | 4.169 | 4.126 | 2.629 | 2.581 | 2.531 | 2.483 | - | - | - | - |
| Cash | 998 | 1.298 | 324 | 165 | 162 | 159 | - | - | - | - |
| Shareholders Funds | -32.935 | -50.368 | -58.893 | -71.544 | -70.158 | -68.828 | - | - | - | - |
| Social Capital | 751 | 743 | 731 | 717 | 703 | 690 | - | - | - | - |
| Debts | 38.145 | 55.835 | 61.888 | 74.331 | 72.891 | 71.509 | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2660 - 2660" | |||||||||
| CAEN Financial Year |
2660
|
|||||||||
Comments - Odelga Med Srl